LISATA THERAPEUTICS, INC. Temporary Equity, Elimination as Part of Reorganization
LISATA THERAPEUTICS, INC. (LSTA) reported Temporary Equity, Elimination as Part of Reorganization of $3.69 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-14.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityEliminationAsPartofReorganization · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. temporary equity, elimination as part of reorganization for the quarter ending 2017-12-31 was -$526.00.
- LISATA THERAPEUTICS, INC. temporary equity, elimination as part of reorganization for the quarter ending 2017-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. temporary equity, elimination as part of reorganization for fiscal 2017 was $3.69M.
| Period end | Temporary Equity, Elimination as Part of Reorganization 3 month | Temporary Equity, Elimination as Part of Reorganization 6 month | Temporary Equity, Elimination as Part of Reorganization 9 month | Temporary Equity, Elimination as Part of Reorganization 12 month | Temporary Equity, Elimination as Part of Reorganization 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | -$526.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$526.00 derived: sum of 2 quarters · filed 2019-03-14 | $3.69M 10-K · filed 2019-03-14 | $3.69M 10-K · filed 2018-03-22 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.69M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $3.69M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |